Description of medicine: Exosurf for newborns (Exosurf neonatal)
EXOSURF FOR NEWBORNS (Exosurf neonatal).
The active substance of exosurf is colfosceril palmitate (Colfosceril palmitate).
It has surfactant properties and improves lung extensibility.
It is used, like kurosurf, for respiratory distress syndrome in newborns.
Enter in the form of a solution at a dose of 5 ml / kg through an endotracheal tube. If necessary, repeat the introduction in the same dose after 12 hours
Release form: powder in ampoules of 0.108 g of colfoseryl palmitate with the addition of other components complete with a solvent (water for injection) in ampoules of 8 ml.